GeneDx Holdings Corp. Faces Securities Lawsuit Over Alleged Misleading Business Information.

Rosen Law Firm is investigating potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS) regarding allegedly misleading business information. Investors who purchased GeneDx securities may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, visit https://rosenlegal.com/submit-form/?case_id=40333 or call 866-767-3653.

New York, NY - Rosen Law Firm, a globally recognized investor rights law firm, has initiated an investigation into potential securities claims against GeneDx Holdings Corp. (NASDAQ: WGS). The firm is exploring allegations that the company may have issued materially misleading business information to the investing public, potentially entitling investors to compensation.

On February 5, 2025, Grizzly Research published a report titled "Insiders Attest that GeneDx (Nasdaq: WGS) Is Actively Committing Widespread Fraud." The report stated that GeneDx's growth is largely an illusion, driven by fraudulent schemes and illegal tactics aimed at exploiting Medicaid and Medicare systems to artificially inflate revenue. This revelation led to a significant drop in GeneDx's stock price, falling 6.7% on the same day [1].

Rosen Law Firm is preparing a class action seeking recovery of investor losses. Investors who purchased GeneDx securities may be entitled to compensation through a contingency fee arrangement. To join the prospective class action, investors can visit [Rosen Legal](https://rosenlegal.com/submit-form/?case_id=40333) or contact Phillip Kim, Esq. toll-free at 866-767-3653 or via email at case@rosenlegal.com [2].

The Rosen Law Firm is known for its expertise in securities class actions and shareholder derivative litigation, having recovered hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors [3]. Investors are advised to select qualified counsel with a proven track record of success.

References:
[1] https://www.marketscreener.com/news/rosen-nationally-regarded-investor-counsel-encourages-genedx-holdings-corp-investors-to-inquire-a-ce7c50d2d98bff2d
[2] https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-genedx-holdings-corp-investors-to-inquire-about-securities-class-action-investigation--wgs-302542137.html
[3] https://www.ainvest.com/news/genedx-holdings-corp-investigation-potential-securities-claims-2508/